PMN
Price
$0.41
Change
-$0.02 (-4.65%)
Updated
Sep 23, 04:48 PM (EDT)
Capitalization
22.22M
50 days until earnings call
TELIF
Price
$0.21
Change
-$0.01 (-4.55%)
Updated
Sep 22 closing price
Capitalization
12.47M
Interact to see
Advertisement

PMN vs TELIF

Header iconPMN vs TELIF Comparison
Open Charts PMN vs TELIFBanner chart's image
ProMIS Neurosciences
Price$0.41
Change-$0.02 (-4.65%)
Volume$200
Capitalization22.22M
TELESCOPE INNOVATIONS
Price$0.21
Change-$0.01 (-4.55%)
Volume$18.6K
Capitalization12.47M
PMN vs TELIF Comparison Chart in %
Loading...
PMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TELIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PMN vs. TELIF commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMN is a Hold and TELIF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (PMN: $0.43 vs. TELIF: $0.21)
Brand notoriety: PMN and TELIF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PMN: 6% vs. TELIF: 50%
Market capitalization -- PMN: $22.22M vs. TELIF: $12.47M
PMN [@Biotechnology] is valued at $22.22M. TELIF’s [@Biotechnology] market capitalization is $12.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.23B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PMN’s FA Score shows that 0 FA rating(s) are green whileTELIF’s FA Score has 0 green FA rating(s).

  • PMN’s FA Score: 0 green, 5 red.
  • TELIF’s FA Score: 0 green, 5 red.
According to our system of comparison, TELIF is a better buy in the long-term than PMN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PMN’s TA Score shows that 4 TA indicator(s) are bullish while TELIF’s TA Score has 3 bullish TA indicator(s).

  • PMN’s TA Score: 4 bullish, 6 bearish.
  • TELIF’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both PMN and TELIF are a bad buy in the short-term.

Price Growth

PMN (@Biotechnology) experienced а +2.53% price change this week, while TELIF (@Biotechnology) price change was -19.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.94%. For the same industry, the average monthly price growth was +8.31%, and the average quarterly price growth was +48.45%.

Reported Earning Dates

PMN is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+2.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PMN($22.2M) has a higher market cap than TELIF($12.5M). TELIF has higher P/E ratio than PMN: TELIF (85.38) vs PMN (7.78). TELIF YTD gains are higher at: -19.479 vs. PMN (-54.737). TELIF has higher annual earnings (EBITDA): -1.32M vs. PMN (-8.43M). PMN has more cash in the bank: 4.54M vs. TELIF (1.11M). TELIF has less debt than PMN: TELIF (2.22M) vs PMN (4.05M). TELIF has higher revenues than PMN: TELIF (3.97M) vs PMN (0).
PMNTELIFPMN / TELIF
Capitalization22.2M12.5M178%
EBITDA-8.43M-1.32M641%
Gain YTD-54.737-19.479281%
P/E Ratio7.7885.389%
Revenue03.97M-
Total Cash4.54M1.11M409%
Total Debt4.05M2.22M183%
FUNDAMENTALS RATINGS
PMN: Fundamental Ratings
PMN
OUTLOOK RATING
1..100
1
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PMNTELIF
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
55%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 21 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
PMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TELIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HCHDF4.590.41
+9.89%
Hochschild Mining PLC
JPXGY10.760.18
+1.70%
Japan Exchange Group, Inc.
CWPS30.00N/A
N/A
Conwest Associates, L.P.
SYAAF0.19N/A
N/A
Syrah Resources Ltd.
AZRS6.00N/A
N/A
Arculus System Co Ltd.

PMN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMN has been loosely correlated with CNSP. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PMN jumps, then CNSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMN
1D Price
Change %
PMN100%
-2.83%
CNSP - PMN
51%
Loosely correlated
+6.27%
NEVPF - PMN
49%
Loosely correlated
N/A
BBIO - PMN
40%
Loosely correlated
-1.58%
ABOS - PMN
29%
Poorly correlated
+1.59%
LITS - PMN
26%
Poorly correlated
-7.86%
More

TELIF and

Correlation & Price change

A.I.dvisor tells us that TELIF and ATNM have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TELIF and ATNM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TELIF
1D Price
Change %
TELIF100%
-4.55%
ATNM - TELIF
28%
Poorly correlated
+2.52%
RVXCF - TELIF
23%
Poorly correlated
-2.84%
TNFA - TELIF
23%
Poorly correlated
-3.89%
PMN - TELIF
20%
Poorly correlated
-2.83%
REVB - TELIF
10%
Poorly correlated
-1.30%
More